Non-relapsing Secondary Progressive Multiple Sclerosis
1 clinical trials · Condition
◉ Watch Non-relapsing Secondary Progressive Multiple Sclerosis
| Record | Firm | Date |
|---|---|---|
| Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) (NCT04411641) | Sanofi | 2020-09-24 |
Track Non-relapsing Secondary Progressive Multiple Sclerosis automatically
Every clearance here is in the API, with alerts when new ones post.